Resources

Publications

11/05/2024
- Oncology
EVEREST-2: A Seamless Phase 1/2 Study of A2B694, a Logic-Gated Tmod Car T-Cell Therapy, in Patients With Mesothelin-Expressing Solid Tumors With Human Leukocyte Antigen-A*02 Loss of Heterozygosity
SITC 2024
11/05/2024
- Oncology
EVEREST-1: Initial Safety Data From a Seamless Phase 1/2 Study of A2B530, a Logic-Gated Tmod Car T-Cell Therapy, in Patients With Solid Tumors Associated With Cea Expression Also Exhibiting HLA-LOH
SITC 2024
11/05/2024
- Oncology
ASPSCR1::TFE3 Type-1 vs. Type-2 Fusions in Alveolar Soft Part Sarcoma (ASPS) Display a Differential Tumor Immune Microenvironment (TIME) Influencing Response to Immune Checkpoint Inhibitors (ICIs)
SITC 2024
11/05/2024
- Oncology
Variable Associations Between Humoral Immune Features And Immune Checkpoint Blockade-Related Outcomes Across Tissues In Metastatic Lung Adenocarcinoma
SITC 2024
11/05/2024
- Oncology
Self-Supervised Representation Learning Enables Genomic Prediction at Single-Organoid Resolution
SITC 2024
11/05/2024
- Oncology
POLE/POLD1 Mutations As Predictive Biomarkers for Immunotherapy Response: Insights From a Pan-Cancer Real-World Dataset
SITC 2024
11/05/2024
- Oncology
Impact of Timing of Real-World CT Imaging on Cost-Effectiveness of a Molecular Biomarker for Treatment Response Monitoring of Immunotherapy
SITC 2024
11/05/2024
- Oncology
Clinical Validation of a Novel Multi-Omic Algorithm for Stratifying Outcomes in a Real-World Cohort of Metastatic Solid Cancer Patients Treated With Immune Checkpoint Inhibitors
SITC 2024
11/04/2024
- Oncology
Actionable Structural Variant Detection via RNA-NGS and DNA-NGS in Patients With Advanced Non–Small Cell Lung Cancer
JAMA Network Open
11/01/2024
- Oncology
Onvansertib in Combination With Chemotherapy and Bevacizumab in Second-Line Treatment of KRAS-Mutant Metastatic Colorectal Cancer: A Single-Arm, Phase II Trial
Journal of Clinical Oncology

14 15 16